Scott Leftwich - Aug 21, 2025 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Role
Director
Signature
/s/ Andrew Jackson, Attorney-in-fact
Stock symbol
CLDI
Transactions as of
Aug 21, 2025
Transactions value $
$250,000
Form type
4
Date filed
8/25/2025, 08:47 PM
Previous filing
Jul 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leftwich Scott Director C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, /s/ Andrew Jackson, Attorney-in-fact 2025-08-25 0001991668

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDI Common Stock Purchase $250K +125K +2212.39% $2.00 131K Aug 21, 2025 Direct F1, F2
holding CLDI Common Stock 14.7K Aug 21, 2025 By SECBL, LLC F3
holding CLDI Common Stock 1.31K Aug 21, 2025 By WEBCL, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDI Warrant (right to buy) Purchase +125K 125K Aug 21, 2025 Common stock 125K $2.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
F2 Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.
F3 The reporting person is the managing member of SECBL, LLC and WEBCL, LLC, as such the reporting person may be deemed to have beneficial ownership of the common stock held by SECBL, LLC and WEBCL, LLC.

Remarks:

Exhibit 24 - Power of Attorney (previously filed as Exhibit 24 to Form 4 dated July 2, 2024.)